177 related articles for article (PubMed ID: 35210278)
1. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Jones BV; Yeom KW; Onar-Thomas A; Dunkel IJ; Fouladi M; Fangusaro JR; Poussaint TY
AJNR Am J Neuroradiol; 2022 Mar; 43(3):455-461. PubMed ID: 35210278
[TBL] [Abstract][Full Text] [Related]
2. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
[TBL] [Abstract][Full Text] [Related]
3. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
[TBL] [Abstract][Full Text] [Related]
4. Correlation of
Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Fangusaro J; Onar-Thomas A; Poussaint TY; Wu S; Ligon AH; Lindeman N; Campagne O; Banerjee A; Gururangan S; Kilburn LB; Goldman S; Qaddoumi I; Baxter P; Vezina G; Bregman C; Patay Z; Jones JY; Stewart CF; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Neuro Oncol; 2021 Oct; 23(10):1777-1788. PubMed ID: 33631016
[TBL] [Abstract][Full Text] [Related]
6. MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of
Trasolini A; Erker C; Cheng S; Crowell C; McFadden K; Moineddin R; Sargent MA; Mata-Mbemba D
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1196-1201. PubMed ID: 35863783
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
[TBL] [Abstract][Full Text] [Related]
8. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
Banerjee A; Jakacki RI; Onar-Thomas A; Wu S; Nicolaides T; Young Poussaint T; Fangusaro J; Phillips J; Perry A; Turner D; Prados M; Packer RJ; Qaddoumi I; Gururangan S; Pollack IF; Goldman S; Doyle LA; Stewart CF; Boyett JM; Kun LE; Fouladi M
Neuro Oncol; 2017 Aug; 19(8):1135-1144. PubMed ID: 28339824
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.
Rameh V; Vajapeyam S; Ziaei A; Kao P; London WB; Baker SJ; Chiang J; Lucas J; Tinkle CL; Wright KD; Poussaint TY
AJNR Am J Neuroradiol; 2023 Jul; 44(7):833-840. PubMed ID: 37321859
[TBL] [Abstract][Full Text] [Related]
10. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
[TBL] [Abstract][Full Text] [Related]
11. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
[TBL] [Abstract][Full Text] [Related]
12. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E
J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663
[TBL] [Abstract][Full Text] [Related]
13. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
Eckstein OS; Allen CE; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey B; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga J; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
J Clin Oncol; 2022 Jul; 40(20):2235-2245. PubMed ID: 35363510
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
15. Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity.
Ryu YJ; Choi SH; Park SJ; Yun TJ; Kim JH; Sohn CH
PLoS One; 2014; 9(9):e108335. PubMed ID: 25268588
[TBL] [Abstract][Full Text] [Related]
16. Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.
Thust SC; Maynard JA; Benenati M; Wastling SJ; Mancini L; Jaunmuktane Z; Brandner S; Jäger HR
AJNR Am J Neuroradiol; 2021 Mar; 42(3):441-447. PubMed ID: 33414227
[TBL] [Abstract][Full Text] [Related]
17. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
18. Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile.
Gihr G; Horvath-Rizea D; Hekeler E; Ganslandt O; Henkes H; Hoffmann KT; Scherlach C; Schob S
PLoS One; 2021; 16(4):e0249878. PubMed ID: 33857203
[TBL] [Abstract][Full Text] [Related]
19. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
20. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
Aboian MS; Tong E; Solomon DA; Kline C; Gautam A; Vardapetyan A; Tamrazi B; Li Y; Jordan CD; Felton E; Weinberg B; Braunstein S; Mueller S; Cha S
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1804-1810. PubMed ID: 31694820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]